A Clinical Study in Male Pediatric Patients With Cerebral X-linked Adrenoleukodystrophy (Cald) to Assess the Effects of MIN-102 Treatment on Disease Progression Prior to Human Stem Cell Transplant (HSCT)

NCT04528706 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Cerebral Adrenoleukodystrophy

Interventions

DRUG: MIN-102

Sponsor

Minoryx Therapeutics, S.L.